More on TPST
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.21 |
|
|||
| Open | $1.21 | ||||
| 52 Wk High | $0.01 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $1.21 | ||||
| Day Low | $1.21 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 958,729 | ||||
- Form DEFA14A Tempest Therapeutics,
- Form 8-K Tempest Therapeutics, For: Sep 15
- Form 8-K Tempest Therapeutics, For: Sep 11
- Tempest Therapeutics options CD7 lentiviral CAR-T platform from Senlang
- Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
- Tempest Therapeutics raises $2.5M in private placement
- Tempest Therapeutics Announces Up to $7.5 Million Private Placement
- Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Form 8-K Tempest Therapeutics, For: Aug 18
- Form S-1 Tempest Therapeutics,
Entities mentioned with TPST
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S3 | View Related Stories »
- Show More...
